Although its function and signalling is yet unclear, CEA is overexpressed in 98.8% of CRC tissues, so it is a useful diagnostic and prognostic tumour marker, as well as a promising target for novel treatments against CRC [43,44]. This evidence concerns the gene CEACAM5 and colorectal carcinoma.